Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP735019.RAMq2TOeFDgXvS5ioAgelrdnnBAz42O87EGG9grLx6f1g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP735019.RAMq2TOeFDgXvS5ioAgelrdnnBAz42O87EGG9grLx6f1g130_assertion type Assertion NP735019.RAMq2TOeFDgXvS5ioAgelrdnnBAz42O87EGG9grLx6f1g130_head.
- NP735019.RAMq2TOeFDgXvS5ioAgelrdnnBAz42O87EGG9grLx6f1g130_assertion description "[In haplotype analysis, CCGAG haplotype in CD27 and TAA haplotype in CD70 conferred an increased risk of breast cancer (P = 5.60 � 10(-3); P = 7.75 � 10(-5), respectively), but TGC, TAC and TGA haplotypes in CD70 were associated with a decreased risk of breast cancer (P = 0.01; P = 5.2 � 10(-3); P = 2.00 � 10(-3), respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP735019.RAMq2TOeFDgXvS5ioAgelrdnnBAz42O87EGG9grLx6f1g130_provenance.
- NP735019.RAMq2TOeFDgXvS5ioAgelrdnnBAz42O87EGG9grLx6f1g130_assertion evidence source_evidence_literature NP735019.RAMq2TOeFDgXvS5ioAgelrdnnBAz42O87EGG9grLx6f1g130_provenance.
- NP735019.RAMq2TOeFDgXvS5ioAgelrdnnBAz42O87EGG9grLx6f1g130_assertion SIO_000772 22399187 NP735019.RAMq2TOeFDgXvS5ioAgelrdnnBAz42O87EGG9grLx6f1g130_provenance.
- NP735019.RAMq2TOeFDgXvS5ioAgelrdnnBAz42O87EGG9grLx6f1g130_assertion wasDerivedFrom befree-20150227 NP735019.RAMq2TOeFDgXvS5ioAgelrdnnBAz42O87EGG9grLx6f1g130_provenance.
- NP735019.RAMq2TOeFDgXvS5ioAgelrdnnBAz42O87EGG9grLx6f1g130_assertion wasGeneratedBy ECO_0000203 NP735019.RAMq2TOeFDgXvS5ioAgelrdnnBAz42O87EGG9grLx6f1g130_provenance.